Curaleaf Holdings (CSE:CURA) Has Debt But No Earnings; Should You Worry?
May 28
Canadian (TSX) Pharma Industry Analysis
UpdatedJun 08, 2023
DataAggregated Company Financials
Companies121
- 7D-1.1%
- 3M-21.8%
- 1Y-54.3%
- YTD-26.5%
The Pharma industry is down 4.8% over the last week with Green Thumb Industries the worst performer, down 5.5%. In contrast, iAnthus Capital Holdings has gained 20%. However, the industry is down 56% over the past year. Looking forward, earnings are forecast to grow by 78% annually.
Industry Valuation and Performance
Has the Canadian Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 08 Jun 2023 | CA$14.6b | CA$13.3b | -CA$10,398,674,708.00 | 10.3x | -1.4x | 1.1x |
| Sat, 06 May 2023 | CA$16.5b | CA$13.3b | -CA$10,297,242,673.00 | 11.1x | -1.6x | 1.2x |
| Mon, 03 Apr 2023 | CA$16.3b | CA$13.4b | -CA$10,036,187,625.00 | 8.7x | -1.6x | 1.2x |
| Wed, 01 Mar 2023 | CA$19.3b | CA$13.7b | -CA$10,254,161,221.00 | 9.8x | -1.9x | 1.4x |
| Fri, 27 Jan 2023 | CA$19.0b | CA$13.5b | -CA$10,087,001,268.00 | 14.4x | -1.9x | 1.4x |
| Sun, 25 Dec 2022 | CA$20.0b | CA$13.6b | -CA$10,151,710,113.00 | 12.4x | -2x | 1.5x |
| Tue, 22 Nov 2022 | CA$29.1b | CA$13.5b | -CA$10,230,610,337.00 | 10.4x | -2.8x | 2.2x |
| Thu, 20 Oct 2022 | CA$27.7b | CA$13.5b | -CA$9,430,518,444.00 | 11.4x | -2.9x | 2.1x |
| Sat, 17 Sep 2022 | CA$28.4b | CA$13.1b | -CA$8,843,772,737.00 | 13.8x | -3.2x | 2.2x |
| Mon, 15 Aug 2022 | CA$29.3b | CA$12.5b | -CA$8,212,978,013.00 | 13.2x | -3.6x | 2.3x |
| Wed, 13 Jul 2022 | CA$26.0b | CA$12.2b | -CA$5,775,145,638.00 | 10.4x | -4.5x | 2.1x |
| Fri, 10 Jun 2022 | CA$30.4b | CA$12.2b | -CA$5,480,470,272.00 | 9.9x | -5.5x | 2.5x |
| Sun, 08 May 2022 | CA$34.6b | CA$12.0b | -CA$4,925,777,728.00 | 11.6x | -7x | 2.9x |
| Tue, 05 Apr 2022 | CA$44.6b | CA$11.6b | -CA$4,640,383,890.00 | 13.3x | -9.6x | 3.8x |
| Thu, 03 Mar 2022 | CA$42.5b | CA$10.6b | -CA$4,454,287,976.00 | 13.5x | -9.5x | 4x |
| Sat, 29 Jan 2022 | CA$44.4b | CA$10.9b | -CA$4,933,422,632.00 | 11.6x | -9x | 4.1x |
| Mon, 27 Dec 2021 | CA$54.9b | CA$10.9b | -CA$4,964,997,894.00 | 13.5x | -11.1x | 5x |
| Wed, 24 Nov 2021 | CA$65.1b | CA$10.8b | -CA$4,877,103,503.00 | 19.6x | -13.3x | 6x |
| Fri, 22 Oct 2021 | CA$63.7b | CA$10.1b | -CA$4,883,044,951.00 | 19.2x | -13x | 6.3x |
| Sun, 19 Sep 2021 | CA$66.8b | CA$10.4b | -CA$6,658,476,418.00 | 21.4x | -10x | 6.4x |
| Tue, 17 Aug 2021 | CA$69.0b | CA$10.2b | -CA$6,616,236,433.27 | 22.3x | -10.4x | 6.8x |
| Tue, 01 Jun 2021 | CA$81.6b | CA$8.9b | -CA$7,509,828,145.21 | 24.4x | -10.9x | 9.2x |
| Fri, 05 Mar 2021 | CA$92.2b | CA$7.6b | -CA$8,166,561,132.27 | 44.4x | -11.3x | 12.2x |
| Mon, 07 Dec 2020 | CA$59.6b | CA$6.6b | -CA$10,071,038,851.76 | 26.4x | -5.9x | 9.1x |
| Thu, 10 Sep 2020 | CA$41.1b | CA$5.6b | -CA$8,989,610,861.79 | 23.1x | -4.6x | 7.4x |
Price to Earnings Ratio
-3.8x
Current Industry PE
- Investors are pessimistic on the Canadian Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 5.2x is higher than the industry's current PS ratio of 1.1x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have deteriorated over the last three years.
- Meanwhile revenues for these companies have grown 34% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.
Industry Comparison
How does Canadian Pharma compare with similar industries?
| CA Market | 2.01% | |
| Healthcare | 0.52% | |
| Pharma | -1.14% | |
| Pharma | -1.14% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| CURA Curaleaf Holdings | CA$4.05 | 4.7% +CA$129.4m | -46.3% | PS1.6x | |
| IAN iAnthus Capital Holdings | CA$0.03 | 20.0% +CA$32.2m | -66.7% | PS0.9x | |
| GSD Devonian Health Group | CA$0.28 | 52.8% +CA$15.2m | -54.2% | PS18x | |
| GUD Knight Therapeutics | CA$4.93 | 2.7% +CA$14.2m | -7.0% | PS1.7x | |
| OGI Organigram Holdings | CA$0.55 | 7.8% +CA$12.9m | -61.3% | PS1.1x |
